期刊文献+

黛力新在治疗伴有情感障碍慢性紧张型头痛中的价值

Effect of Deanxit in Chronic Tension Headache Patients Associated with Affective Disorder
暂未订购
导出
摘要 目的:评价黛力新对改善伴有情感障碍慢性紧张型头痛(CTH)患者焦虑及抑郁指数的效果。方法:60例患者随机分为黛力新组(黛力新、鲁南贝特和硫必利),对照组(鲁南贝特和硫必利),疗程6周;于治疗前及治疗后2、4、6周末,用汉密尔顿焦虑量表(HAMA)和汉密尔顿抑郁量表(HAMD)评价患者焦虑和抑郁指数,行重复测量方差分析和多元方差分析。结果:HAMA和HAMD评分均随时间变化而变化(HAMA:F=501.073:HAMD:F=1123.157,均P<0.001),而且时间与分组均有交互作用,即组间评分均随时间变化趋势而不同(HAMA:F=191.855;HAMD:F=152.491,均P<0.001)。结论:黛力新对改善伴有情感障碍CTH患者的焦虑及抑郁指数较常规止痛剂效果好。 Objective To evaluate the efficacy of deanxit in chronic tension headache (CTH) patients associated with affective disorder on anxiety and depression index. Methods Sixty patients enrolled were randomly divided into deanxit group and control, each group has 30 patients. The patients in deanxit group were treated with Deanxit, Paracetamol, Chlorzoxazone Dispersible and Tiapride for 6 weeks, while the patients in control group were only treated with Compound Chlorzoxazone and Tiapride for 6 weeks.The patients were scored on anxiety and depression index according to Hanmierdun Anxiety Scale (HAMP)and Hanmierdun Anxiety scale (HAMA)before and 2, 4, and 6 weeks after treatment. Then, the results were evaluated by repeated measurement of variance analysis and multivariate analysis of variance. Results HAMA and HAMD grades varied with time (HAMA:F=501.073, HAMD:F=1123.157, each P〈0.001), and there was a interaction of time with group division, that is, in the same group, the scores were different with time (HAMA:F=191.855, HAMD:F=152.491, each P〈0.001) ; Conclusion In CTH patients associated with affective disorder, the therapeutic effect of Deanxit is much better than general analgetics on improving anxiety and depression index.
出处 《郧阳医学院学报》 2008年第1期35-38,共4页 Journal of Yunyang Medical College
关键词 黛力新 情感障碍 慢性紧张型头痛 焦虑指数 抑郁指数 重复测量方差分析 Deanxit Affective disorder , Chronic tension headache Anxiety index Depression index Repeated measure ment of variance analysis
  • 相关文献

参考文献9

二级参考文献41

  • 1黄永刚,邓小明,许华.抗抑郁治疗与疼痛控制[J].实用诊断与治疗杂志,2005,19(1):36-38. 被引量:17
  • 2Eingel E.临床应用黛安神15年经验体会[J].深圳新药特药通讯,1996,1(9):7-9.
  • 3ADELMAN LC,ADELMAN JU,von SEGGERN R,et al.Venlafaxine extended release(XR)for the prophylaxis of migraine and tension-type headache:a retrospective study in a clinical setting[J].Headache,2000,40 (7):572-580.
  • 4YUCEL B,KORA K,OZYALCIN S,et al.Depression automatic thoughts,alexithymia,and assertiveness in patients with tensiontype headache[J].Headache,2002,42 (3):194-199.
  • 5ZWART J A,DYB G,HAGEN K,et al.Depression and anxiety disorders associated with headache frequency[J].Eur J Neurol,2003,10(2):147-152.
  • 6[2]Marukawa H,Takahash K.Headche,1996,36:100.
  • 7Headache Classification Committee of the International Headache Society.Classification and diagnostic Creteria for headache disorders,Cranial neuralgias,and facial pain[J].Cephalalgia,1988,8(Sup):1-96.
  • 8Bussone G, Baldini S,D'Andrea G,et al.Nimodipine Versus flunarizaine in common Migraine[J]. Headache,1987,27:76-79.
  • 9Schwartz BS, Stewart WF, Simon D, et al. Epidemiology of tension-type headache[J].JAMA,1998,279:381-386.
  • 10虞容豪 张幸运.黛安神治疗伴抑郁、焦虑状态的偏头痛[J].中国临床心理学杂志,1997,5:76-77.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部